BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bisteau X, Caldez MJ, Kaldis P. The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations. Cancers (Basel) 2014;6:79-111. [PMID: 24419005 DOI: 10.3390/cancers6010079] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin G, Sun W, Yang Z, Guo J, Liu H, Liang J. Hypoxia induces the expression of TET enzymes in HepG2 cells. Oncol Lett 2017;14:6457-62. [PMID: 29163682 DOI: 10.3892/ol.2017.7063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chang-Lee SN, Hsu HH, Shibu MA, Ho TJ, Tsai CH, Chen MC, Tu CC, Viswanadha VP, Kuo WW, Huang CY. E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma. Pathol Oncol Res 2017;23:477-85. [PMID: 27757837 DOI: 10.1007/s12253-016-0136-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
3 Fifield BA, Talia J, Stoyanovich C, Elliott MJ, Bakht MK, Basilious A, Samsoondar JP, Curtis M, Stringer KF, Porter LA. Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation. Carcinogenesis 2020;41:850-62. [PMID: 31574533 DOI: 10.1093/carcin/bgz164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lim JJ, Dutta M, Dempsey JL, Lehmler HJ, MacDonald J, Bammler T, Walker C, Kavanagh TJ, Gu H, Mani S, Cui JY. Neonatal Exposure to BPA, BDE-99, and PCB Produces Persistent Changes in Hepatic Transcriptome Associated With Gut Dysbiosis in Adult Mouse Livers. Toxicol Sci 2021;184:83-103. [PMID: 34453844 DOI: 10.1093/toxsci/kfab104] [Reference Citation Analysis]
5 Wright T, Wang Y, Bedford MT. The Role of the PRMT5-SND1 Axis in Hepatocellular Carcinoma. Epigenomes 2021;5:2. [PMID: 33768972 DOI: 10.3390/epigenomes5010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Palmer N, Kaldis P. Regulation of the Embryonic Cell Cycle During Mammalian Preimplantation Development. Curr Top Dev Biol 2016;120:1-53. [PMID: 27475848 DOI: 10.1016/bs.ctdb.2016.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
7 Sonntag R, Giebeler N, Nevzorova YA, Bangen JM, Fahrenkamp D, Lambertz D, Haas U, Hu W, Gassler N, Cubero FJ, Müller-Newen G, Abdallah AT, Weiskirchen R, Ticconi F, Costa IG, Barbacid M, Trautwein C, Liedtke C. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma. Proc Natl Acad Sci U S A 2018;115:9282-7. [PMID: 30150405 DOI: 10.1073/pnas.1807155115] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 7.5] [Reference Citation Analysis]
8 Aboughaleb IH, Matboli M, Shawky SM, El-Sharkawy YH. Integration of transcriptomes analysis with spectral signature of total RNA for generation of affordable remote sensing of Hepatocellular carcinoma in serum clinical specimens. Heliyon 2021;7:e06388. [PMID: 33748469 DOI: 10.1016/j.heliyon.2021.e06388] [Reference Citation Analysis]
9 Wu SY, Lan SH, Wu SR, Chiu YC, Lin XZ, Su IJ, Tsai TF, Yen CJ, Lu TH, Liang FW, Li CY, Su HJ, Su CL, Liu HS. Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system. Hepatology 2018;68:141-54. [PMID: 29328502 DOI: 10.1002/hep.29781] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
10 Zhao L, Dai C, Gong Q. Changes of Endocan and its effect on hepatic stem cells during the rapid proliferation process of residual liver after ALPPS procedure. Cell Biochem Funct 2020;38:817-25. [PMID: 32515027 DOI: 10.1002/cbf.3553] [Reference Citation Analysis]
11 Velasco-loyden G, Pérez-martínez L, Vidrio-gómez S, Pérez-carreón JI, Chagoya de Sánchez V. Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats. Tumour Biol 2017;39:101042831769119. [DOI: 10.1177/1010428317691190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
12 Patel S, Gogna P. Tapping botanicals for essential oils: Progress and hurdles in cancer mitigation. Industrial Crops and Products 2015;76:1148-63. [DOI: 10.1016/j.indcrop.2015.08.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
13 Dharanipragada P, Seelam SR, Parekh N. SeqVItA: Sequence Variant Identification and Annotation Platform for Next Generation Sequencing Data. Front Genet 2018;9:537. [PMID: 30487811 DOI: 10.3389/fgene.2018.00537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Jindal A, Thadi A, Shailubhai K. Hepatocellular Carcinoma: Etiology and Current and Future Drugs. J Clin Exp Hepatol 2019;9:221-32. [PMID: 31024205 DOI: 10.1016/j.jceh.2019.01.004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 20.7] [Reference Citation Analysis]
15 Sheng X, Qin JM. Clinical features and diagnostic and therapeutic strategies of hepatic dysplastic nodules. Shijie Huaren Xiaohua Zazhi 2022; 30(4): 169-181 [DOI: 10.11569/wcjd.v30.i4.169] [Reference Citation Analysis]
16 Wang J, Liu Q, Shyr Y. Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis. BMC Genomics 2015;16 Suppl 7:S5. [PMID: 26100984 DOI: 10.1186/1471-2164-16-S7-S5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
17 Pocasap P, Weerapreeyakul N, Wongpoomchai R. Chemopreventive Effect of Cratoxylum formosum (Jack) ssp. pruniflorum on Initial Stage Hepatocarcinogenesis in Rats. Molecules 2021;26:4235. [PMID: 34299510 DOI: 10.3390/molecules26144235] [Reference Citation Analysis]
18 Jeyaram C, Philip M, Perumal RC, Benny J, Jayakumari JM, Ramasamy MS. A Computational Approach to Identify Novel Potential Precursor miRNAs and their Targets from Hepatocellular Carcinoma Cells. CBIO 2018;14:24-32. [DOI: 10.2174/1574893613666180413150351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Shan S, Chen W, Jia JD. Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development. Front Genet 2019;10:305. [PMID: 31001331 DOI: 10.3389/fgene.2019.00305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
20 Cervello M, Emma MR, Augello G, Cusimano A, Giannitrapani L, Soresi M, Akula SM, Abrams SL, Steelman LS, Gulino A, Belmonte B, Montalto G, McCubrey JA. New landscapes and horizons in hepatocellular carcinoma therapy. Aging (Albany NY) 2020;12:3053-94. [PMID: 32018226 DOI: 10.18632/aging.102777] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
21 Ye Q, Liu K, Shen Q, Li Q, Hao J, Han F, Jiang RW. Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids. Front Oncol 2019;9:487. [PMID: 31245292 DOI: 10.3389/fonc.2019.00487] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
22 Nong S, Chen X, Wang Z, Xu G, Wei W, Peng B, Zhou L, Wei L, Zhao J, Wei Q, Deng Y, Meng L. Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network. Biomed Res Int 2021;2021:9972011. [PMID: 34692847 DOI: 10.1155/2021/9972011] [Reference Citation Analysis]
23 Shen S, Dean DC, Yu Z, Duan Z. Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway. Hepatol Res 2019;49:1097-108. [PMID: 31009153 DOI: 10.1111/hepr.13353] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
24 Chen W, Desert R, Ge X, Han H, Song Z, Das S, Athavale D, You H, Nieto N. The Matrisome Genes From Hepatitis B-Related Hepatocellular Carcinoma Unveiled. Hepatol Commun 2021;5:1571-85. [PMID: 34510837 DOI: 10.1002/hep4.1741] [Reference Citation Analysis]
25 Mukherjee S, Kar A, Khatun N, Datta P, Biswas A, Barik S. Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures. Cells 2021;10:1917. [PMID: 34440687 DOI: 10.3390/cells10081917] [Reference Citation Analysis]
26 Trescher S, Münchmeyer J, Leser U. Estimating genome-wide regulatory activity from multi-omics data sets using mathematical optimization. BMC Syst Biol 2017;11:41. [PMID: 28347313 DOI: 10.1186/s12918-017-0419-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
27 da Silva TC, Cogliati B, Latorre AO, Akisue G, Nagamine MK, Haraguchi M, Hansen D, Sanches DS, Dagli ML. Pfaffosidic Fraction from Hebanthe paniculata Induces Cell Cycle Arrest and Caspase-3-Induced Apoptosis in HepG2 Cells. Evid Based Complement Alternat Med 2015;2015:835796. [PMID: 26075002 DOI: 10.1155/2015/835796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Liao Y, Wu N, Wang K, Wang M, Wang Y, Gao J, Zhong B, Ma F, Wu Y, Jiang N. OTUB1 Promotes Progression and Proliferation of Prostate Cancer via Deubiquitinating and Stabling Cyclin E1. Front Cell Dev Biol 2020;8:617758. [PMID: 33537306 DOI: 10.3389/fcell.2020.617758] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Liu D, Wang Z, Zhong L, Xie C, Huang X, Zhi Y, Zhang Y, Liang J, Shi Z, Huang J, Zhang S, Zhang J, Ding F, Raza F. Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/8762717] [Reference Citation Analysis]
30 Farzaneh Z, Vosough M, Agarwal T, Farzaneh M. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell Int 2021;21:208. [PMID: 33849569 DOI: 10.1186/s12935-021-01924-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ortiz-martinez M, Gonzalez de Mejia E, García-lara S, Aguilar O, Lopez-castillo LM, Otero-pappatheodorou JT. Antiproliferative effect of peptide fractions isolated from a quality protein maize, a white hybrid maize, and their derived peptides on hepatocarcinoma human HepG2 cells. Journal of Functional Foods 2017;34:36-48. [DOI: 10.1016/j.jff.2017.04.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 6.4] [Reference Citation Analysis]
32 Zhang H, Tian F, Jiang P, Qian S, Dai X, Ma B, Wang M, Dai H, Sha X, Yang Z, Zhu X, Sun X. Solasonine Suppresses the Proliferation of Acute Monocytic Leukemia Through the Activation of the AMPK/FOXO3A Axis. Front Oncol 2020;10:614067. [PMID: 33585239 DOI: 10.3389/fonc.2020.614067] [Reference Citation Analysis]
33 Xia ZS, Wu D, Zhong W, Lu XJ, Yu T, Chen QK. Wip1 gene silencing enhances the chemosensitivity of human colon cancer cells. Oncol Lett 2017;14:1875-83. [PMID: 28781635 DOI: 10.3892/ol.2017.6361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
34 Mangueira VM, Batista TM, Brito MT, Sousa TKG, Cruz RMDD, Abrantes RA, Veras RC, Medeiros IA, Medeiros KKP, Pereira ALDC, Serafim VL, Moura RO, Sobral MV. A new acridine derivative induces cell cycle arrest and antiangiogenic effect on Ehrlich ascites carcinoma model. Biomed Pharmacother 2017;90:253-61. [PMID: 28364597 DOI: 10.1016/j.biopha.2017.03.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
35 Zhang D, Liu E, Kang J, Yang X, Liu H. MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma. Oncotarget. 2017;8:93014-93028. [PMID: 29190974 DOI: 10.18632/oncotarget.21745] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
36 Wang J, Wei H, Huang Y, Chen D, Zeng G, Lian Y, Huang Y. The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells. Aging (Albany NY) 2019;11:5769-85. [PMID: 31409760 DOI: 10.18632/aging.102165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Tian F, Yu C, Wu M, Wu X, Wan L, Zhu X. MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis. Cell Prolif 2019;52:e12635. [PMID: 31334580 DOI: 10.1111/cpr.12635] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
38 Poojari R, Sawant AV, Kini S, Srivastava R, Panda D. Antihepatoma activity of multifunctional polymeric nanoparticles via inhibition of microtubules and tyrosine kinases. Nanomedicine (Lond) 2020;15:381-96. [PMID: 31990235 DOI: 10.2217/nnm-2019-0349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Scarzello AJ, Jiang Q, Back T, Dang H, Hodge D, Hanson C, Subleski J, Weiss JM, Stauffer JK, Chaisaingmongkol J, Rabibhadana S, Ruchirawat M, Ortaldo J, Wang XW, Norris PS, Ware CF, Wiltrout RH. LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut 2016;65:1765-75. [PMID: 26206664 DOI: 10.1136/gutjnl-2014-308810] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
40 Ehedego H, Mohs A, Jansen B, Hiththetiya K, Sicinski P, Liedtke C, Trautwein C. Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury. Oncogene 2018;37:3329-39. [PMID: 29551768 DOI: 10.1038/s41388-018-0181-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
41 Zahid KR, Su M, Khan ARR, Han S, Deming G, Raza U. Systems biology based meth-miRNA-mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progression. Cancer Cell Int 2019;19:89. [PMID: 31007607 DOI: 10.1186/s12935-019-0804-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
42 Khan MGM, Ghosh A, Variya B, Santharam MA, Ihsan AU, Ramanathan S, Ilangumaran S. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma. BMC Cancer 2020;20:774. [PMID: 32807134 DOI: 10.1186/s12885-020-07285-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
43 Zhang L, Chen J, Yang H, Pan C, Li H, Luo Y, Cheng T. Multiple microarray analyses identify key genes associated with the development of Non-Small Cell Lung Cancer from Chronic Obstructive Pulmonary Disease. J Cancer 2021;12:996-1010. [PMID: 33442399 DOI: 10.7150/jca.51264] [Reference Citation Analysis]
44 Lou Z, Gong YQ, Zhou X, Hu GH. Low expression of miR-199 in hepatocellular carcinoma contributes to tumor cell hyper-proliferation by negatively suppressing XBP1. Oncol Lett 2018;16:6531-9. [PMID: 30405792 DOI: 10.3892/ol.2018.9476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
45 Poojari R, Srivastava R, Panda D. Microtubule targeted therapeutics loaded polymeric assembled nanospheres for potentiation of antineoplastic activity. Faraday Discuss 2016;186:45-59. [DOI: 10.1039/c5fd00123d] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]